Lookup NU author(s): Glenn Renforth,
Dr Neil Hanley,
Dr Karen Piper Hanley,
Dr Vincent Connolly,
Professor Mark Walker,
Dr David Wilson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Alstrom syndrome (OMIM 203800) is an autosomal recessive disease, characterized by cone-rod retinal dystrophy, cardiomyopathy and type 2 diabetes mellitus, that has been mapped to chromosome 2p13 (refs 1-5). We have studied an individual with Alstrom syndrome carrying a familial balanced reciprocal chromosome translocation (46, XY, t(2;11)(p13; q21)mat) involving the previously implicated critical region. We postulated that this individual was a compound heterozygote, carrying one copy of a gene disrupted by the translocation and the other copy disrupted by an intragenic mutation. We mapped the 2p13 breakpoint on the maternal allele to a genomic fragment of 1.7 kb which contains exon 4 and the start of exon 5 of a newly discovered gene (ALMS1); we detected a frameshift mutation in the paternal copy of the gene. The 12.9-kb transcript of ALMS1 encodes a protein of 4,169 amino acids whose function is unknown. The protein contains a large tandem-repeat domain comprising 34 imperfect repetitions of 47 amino acids. We have detected six different mutations (two nonsense and four frameshift mutations causing premature stop codons) in seven families, confirming that ALMS1 is the gene underlying Alstrom syndrome. We believe that ALMS1 is the first human disease gene characterized by autosomal recessive inheritance to be identified as a result of a balanced reciprocal translocation.
Author(s): Walker M; Hanley NA; Renforth GL; Wilson DI; Piper K; Connolly V; Hearn T; Spalluto C; Brickwood S; White C; Taylor JFN; Russell-Eggitt I; Bonneau D
Publication type: Article
Publication status: Published
Journal: Nature Genetics
ISSN (print): 1061-4036
ISSN (electronic): 1546-1718
Publisher: Nature Publishing Group
Altmetrics provided by Altmetric